Does diabetes make cancer treatment harder? new study investigates

NCT ID NCT07466212

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This observational study looks at how having type 2 diabetes impacts quality of life in cancer patients receiving immunotherapy. Researchers will compare changes in well-being over six months between patients with and without diabetes. About 920 adults with solid tumors will fill out quality-of-life surveys at the start, then at 3 and 6 months. The goal is to understand if diabetes adds extra challenges during cancer treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Afdeling for Kræftbehandling, Herlev Hospital

    Herlev, 2730, Denmark

    Contact Email: •••••@•••••

  • Kræftafdelingen, Aarhus Universitetshospital

    Aarhus, 8000, Denmark

    Contact

    Contact Email: •••••@•••••

  • Onkologisk afdeling, Klinik Kirurgi og Kræftbehandling

    Aalborg, 9000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Sygehus Lillebælt, Onkologisk afdeling Vejle

    Vejle, 7100, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact